NZ514012A - Treatment of certain cancers associated with weight gain - Google Patents

Treatment of certain cancers associated with weight gain

Info

Publication number
NZ514012A
NZ514012A NZ514012A NZ51401200A NZ514012A NZ 514012 A NZ514012 A NZ 514012A NZ 514012 A NZ514012 A NZ 514012A NZ 51401200 A NZ51401200 A NZ 51401200A NZ 514012 A NZ514012 A NZ 514012A
Authority
NZ
New Zealand
Prior art keywords
treatment
weight gain
certain cancers
cancers associated
certain
Prior art date
Application number
NZ514012A
Other languages
English (en)
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NZ514012A publication Critical patent/NZ514012A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ514012A 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain NZ514012A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
NZ514012A true NZ514012A (en) 2001-09-28

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ514012A NZ514012A (en) 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain

Country Status (19)

Country Link
EP (1) EP1171106A1 (ja)
JP (1) JP2002539255A (ja)
KR (1) KR20010113765A (ja)
CN (1) CN1399545A (ja)
AU (1) AU3632000A (ja)
BG (1) BG105998A (ja)
BR (1) BR0009161A (ja)
CA (1) CA2367045A1 (ja)
CZ (1) CZ20013281A3 (ja)
HU (1) HUP0200497A2 (ja)
IL (1) IL145239A0 (ja)
MX (1) MXPA01009470A (ja)
NO (1) NO20014478L (ja)
NZ (1) NZ514012A (ja)
PL (1) PL351958A1 (ja)
SK (1) SK13372001A3 (ja)
TR (1) TR200102692T2 (ja)
WO (1) WO2000056323A1 (ja)
ZA (1) ZA200107687B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
JP2002539255A (ja) 2002-11-19
ZA200107687B (en) 2002-12-18
CA2367045A1 (en) 2000-09-28
EP1171106A1 (en) 2002-01-16
WO2000056323A1 (en) 2000-09-28
BG105998A (en) 2002-06-28
PL351958A1 (en) 2003-07-14
SK13372001A3 (sk) 2002-07-02
TR200102692T2 (tr) 2002-03-21
AU3632000A (en) 2000-10-09
MXPA01009470A (es) 2004-03-19
CZ20013281A3 (cs) 2002-07-17
KR20010113765A (ko) 2001-12-28
BR0009161A (pt) 2002-01-22
NO20014478L (no) 2001-10-29
HUP0200497A2 (en) 2002-08-28
IL145239A0 (en) 2002-06-30
NO20014478D0 (no) 2001-09-14
CN1399545A (zh) 2003-02-26

Similar Documents

Publication Publication Date Title
HUP0202363A2 (en) Medicament useful for treating and/or suppressing weight gain
TW401764U (en) Improvement of trunk structure
SI1716853T1 (sl) Zdravljenje rakov äśloveĺ kega telesa z uporabo et743
PL356745A1 (en) Body weight gain inhibitors
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
HK1044111A1 (en) Improved cancer treatment with temozolomide
MXPA01012040A (es) Uso terapeutico de la melatonina.
IL149281A0 (en) Treatment of cancer
IL145239A0 (en) Treatment of certain cancers associated with weight gain
HK1048440A1 (zh) 治療體重增加的方法
GB9911183D0 (en) Treatment of cancers
GB9920670D0 (en) Stabilisation of peroxidases
GB9918534D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
SI1165071T1 (sl) Izboljsano zdravljenje raka s temozolomidom
TW427592U (en) Supporting structure of the rotating body
IL152925A0 (en) Treatment of neuropathy
GB9924958D0 (en) Treatment of neuropathy
TW395204U (en) Improved castor structure of trunk
TW388265U (en) Improved structure of sauna oven
TW429744U (en) Improved structure of pants
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
TW422051U (en) Improved structure of mailbox

Legal Events

Date Code Title Description
AVOD Application void